Literature DB >> 32888273

Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options.

Daniel Dejcman1, Dirk Skowasch2, Carmen Pizarro2, Andreas Krause3, Daniel Thomas4, Valentin Sebastian Schäfer1.   

Abstract

Interstitial lung disease (ILD) is the most common form of pulmonary impairment in patients with rheumatoid arthritis (RA). However, patients with RA or other arthritic diseases such as psoriatic arthritis (PsA) or peripheral spondyloarthritis (pSpA) are at a higher risk of developing several other pulmonary diseases, such as chronic obstructive lung disease (COPD), compared to patients without arthritis. This review aims at summarizing the current knowledge on the prevalence of pulmonary diseases in the above-mentioned forms of arthritis, the challenges faced by prevalence studies in detecting pulmonary diseases in patients with arthritis, as well as possible treatment options. Dyspnea, cough or other pulmonary symptoms in arthritis patients should prompt gradual diagnostic procedures considering pulmonary manifestations as a major cluster of differential diagnosis. However, treatment options often lack solid evidence-based guidelines and referrals to specialized centers are often necessary. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Rheumatoid arthritis; extra-articular manifestation; interstitial lung disease; peripheral spondyloarthritis; psoriatic arthritis; pulmonary manifestation

Year:  2021        PMID: 32888273     DOI: 10.2174/1573397116666200905122757

Source DB:  PubMed          Journal:  Curr Rheumatol Rev        ISSN: 1573-3971


  1 in total

1.  Recurrent pulmonary arteriovenous malformation in a patient with Sjögren syndrome: A case report.

Authors:  Yoon Mi Shin; Yook Kim; Jiyoul Yang; Bumhee Yang; In Ah Choi; Ki Man Lee
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.